Anti-CLDN18.2 heavy chain antibody, related product and application

The invention discloses an anti-CLDN18.2 heavy chain antibody, a related product and application of the anti-CLDN18.2 heavy chain antibody. The heavy-chain antibody is composed of a heavy-chain variable region, the amino acid sequence of CDR1 of the heavy-chain variable region comprises a sequence s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YU XUEJUN, CHEN XIN, DI SHENGMENG, ZHANG SHIWEI, LI ZHAORUN, MA HENG, FENG DONGGE, FAN YANQIU
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YU XUEJUN
CHEN XIN
DI SHENGMENG
ZHANG SHIWEI
LI ZHAORUN
MA HENG
FENG DONGGE
FAN YANQIU
description The invention discloses an anti-CLDN18.2 heavy chain antibody, a related product and application of the anti-CLDN18.2 heavy chain antibody. The heavy-chain antibody is composed of a heavy-chain variable region, the amino acid sequence of CDR1 of the heavy-chain variable region comprises a sequence shown in SEQ ID No.5, the amino acid sequence of CDR2 of the heavy-chain variable region comprises a sequence shown in SEQ ID No.11, and the amino acid sequence of CDR3 of the heavy-chain variable region comprises a sequence shown in SEQ ID No.17. The anti-CLDN18.2 heavy chain antibody provided by the invention only comprises a heavy chain variable region, has high affinity and specificity, can efficiently target a CLDN18.2 antigen, does not recognize CLDN18.1, and is simple in structure and easy to prepare. In addition, the CAR-T cell prepared by using the CAR-T cell can specifically recognize CLDN18.2 positive tumor cells, and can also release various cytokines to efficiently kill the tumor cells. 本申请公开了一种抗CLDN18.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN117903310A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN117903310A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN117903310A3</originalsourceid><addsrcrecordid>eNrjZHB2zCvJ1HX2cfEztNAzUshITSyrVEjOSMzMU0gEyiTlp1TqKBSl5iSWpKYoFBTlp5QmlwBlUhQSCwpyMpMTSzLz83gYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSbyzn6GhuaWBsbGhgaMxMWoAoS8w7g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anti-CLDN18.2 heavy chain antibody, related product and application</title><source>esp@cenet</source><creator>YU XUEJUN ; CHEN XIN ; DI SHENGMENG ; ZHANG SHIWEI ; LI ZHAORUN ; MA HENG ; FENG DONGGE ; FAN YANQIU</creator><creatorcontrib>YU XUEJUN ; CHEN XIN ; DI SHENGMENG ; ZHANG SHIWEI ; LI ZHAORUN ; MA HENG ; FENG DONGGE ; FAN YANQIU</creatorcontrib><description>The invention discloses an anti-CLDN18.2 heavy chain antibody, a related product and application of the anti-CLDN18.2 heavy chain antibody. The heavy-chain antibody is composed of a heavy-chain variable region, the amino acid sequence of CDR1 of the heavy-chain variable region comprises a sequence shown in SEQ ID No.5, the amino acid sequence of CDR2 of the heavy-chain variable region comprises a sequence shown in SEQ ID No.11, and the amino acid sequence of CDR3 of the heavy-chain variable region comprises a sequence shown in SEQ ID No.17. The anti-CLDN18.2 heavy chain antibody provided by the invention only comprises a heavy chain variable region, has high affinity and specificity, can efficiently target a CLDN18.2 antigen, does not recognize CLDN18.1, and is simple in structure and easy to prepare. In addition, the CAR-T cell prepared by using the CAR-T cell can specifically recognize CLDN18.2 positive tumor cells, and can also release various cytokines to efficiently kill the tumor cells. 本申请公开了一种抗CLDN18.</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240419&amp;DB=EPODOC&amp;CC=CN&amp;NR=117903310A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240419&amp;DB=EPODOC&amp;CC=CN&amp;NR=117903310A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YU XUEJUN</creatorcontrib><creatorcontrib>CHEN XIN</creatorcontrib><creatorcontrib>DI SHENGMENG</creatorcontrib><creatorcontrib>ZHANG SHIWEI</creatorcontrib><creatorcontrib>LI ZHAORUN</creatorcontrib><creatorcontrib>MA HENG</creatorcontrib><creatorcontrib>FENG DONGGE</creatorcontrib><creatorcontrib>FAN YANQIU</creatorcontrib><title>Anti-CLDN18.2 heavy chain antibody, related product and application</title><description>The invention discloses an anti-CLDN18.2 heavy chain antibody, a related product and application of the anti-CLDN18.2 heavy chain antibody. The heavy-chain antibody is composed of a heavy-chain variable region, the amino acid sequence of CDR1 of the heavy-chain variable region comprises a sequence shown in SEQ ID No.5, the amino acid sequence of CDR2 of the heavy-chain variable region comprises a sequence shown in SEQ ID No.11, and the amino acid sequence of CDR3 of the heavy-chain variable region comprises a sequence shown in SEQ ID No.17. The anti-CLDN18.2 heavy chain antibody provided by the invention only comprises a heavy chain variable region, has high affinity and specificity, can efficiently target a CLDN18.2 antigen, does not recognize CLDN18.1, and is simple in structure and easy to prepare. In addition, the CAR-T cell prepared by using the CAR-T cell can specifically recognize CLDN18.2 positive tumor cells, and can also release various cytokines to efficiently kill the tumor cells. 本申请公开了一种抗CLDN18.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB2zCvJ1HX2cfEztNAzUshITSyrVEjOSMzMU0gEyiTlp1TqKBSl5iSWpKYoFBTlp5QmlwBlUhQSCwpyMpMTSzLz83gYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSbyzn6GhuaWBsbGhgaMxMWoAoS8w7g</recordid><startdate>20240419</startdate><enddate>20240419</enddate><creator>YU XUEJUN</creator><creator>CHEN XIN</creator><creator>DI SHENGMENG</creator><creator>ZHANG SHIWEI</creator><creator>LI ZHAORUN</creator><creator>MA HENG</creator><creator>FENG DONGGE</creator><creator>FAN YANQIU</creator><scope>EVB</scope></search><sort><creationdate>20240419</creationdate><title>Anti-CLDN18.2 heavy chain antibody, related product and application</title><author>YU XUEJUN ; CHEN XIN ; DI SHENGMENG ; ZHANG SHIWEI ; LI ZHAORUN ; MA HENG ; FENG DONGGE ; FAN YANQIU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN117903310A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>YU XUEJUN</creatorcontrib><creatorcontrib>CHEN XIN</creatorcontrib><creatorcontrib>DI SHENGMENG</creatorcontrib><creatorcontrib>ZHANG SHIWEI</creatorcontrib><creatorcontrib>LI ZHAORUN</creatorcontrib><creatorcontrib>MA HENG</creatorcontrib><creatorcontrib>FENG DONGGE</creatorcontrib><creatorcontrib>FAN YANQIU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YU XUEJUN</au><au>CHEN XIN</au><au>DI SHENGMENG</au><au>ZHANG SHIWEI</au><au>LI ZHAORUN</au><au>MA HENG</au><au>FENG DONGGE</au><au>FAN YANQIU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anti-CLDN18.2 heavy chain antibody, related product and application</title><date>2024-04-19</date><risdate>2024</risdate><abstract>The invention discloses an anti-CLDN18.2 heavy chain antibody, a related product and application of the anti-CLDN18.2 heavy chain antibody. The heavy-chain antibody is composed of a heavy-chain variable region, the amino acid sequence of CDR1 of the heavy-chain variable region comprises a sequence shown in SEQ ID No.5, the amino acid sequence of CDR2 of the heavy-chain variable region comprises a sequence shown in SEQ ID No.11, and the amino acid sequence of CDR3 of the heavy-chain variable region comprises a sequence shown in SEQ ID No.17. The anti-CLDN18.2 heavy chain antibody provided by the invention only comprises a heavy chain variable region, has high affinity and specificity, can efficiently target a CLDN18.2 antigen, does not recognize CLDN18.1, and is simple in structure and easy to prepare. In addition, the CAR-T cell prepared by using the CAR-T cell can specifically recognize CLDN18.2 positive tumor cells, and can also release various cytokines to efficiently kill the tumor cells. 本申请公开了一种抗CLDN18.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN117903310A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
TESTING
VINEGAR
WINE
title Anti-CLDN18.2 heavy chain antibody, related product and application
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A08%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YU%20XUEJUN&rft.date=2024-04-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN117903310A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true